Is It Useful for Coronary Prevention

作者: Nanette K. Wenger

DOI:

关键词:

摘要: Several converging issues have served to highlight the interest in postmenopausal hormone therapy as a coronary preventive intervention for women. First is increased prevalence of heart disease women their menopausal years, with clinical manifestations occurring predominantly older How much this increase risk phenomenon aging versus status remains controversial. Also, earlier onset and greater relative death bilateral oophorectomy or premature ovarian failure emphasizes importance estrogen determinant women.3o, 57 Of great concern are less favorable outcomes than men who defined events, both myocardial infarction revascularization procedures. Further, recent an array biologically plausible mechanisms benefit prevention been reviewed here. Finally, sizable number observational studies that suggest cardiovascular render compelling need evaluate precisely disease-gonadal relationships.

参考文章(30)
David R Holmes, Richard Holubkov, Ronald E Vlietstra, Sheryl F Kelsey, Guy S Reeder, Gerald Dorros, David O Williams, Michael J Cowley, David P Faxon, Kenneth M Kent, Lamberto G Bentivoglio, Katherine Detre, The Co-Investigators of the National, Lung Heart, Percutaneous Transluminal Coronary Angioplasty Registry, None, Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry Journal of the American College of Cardiology. ,vol. 12, pp. 1149- 1155 ,(1988) , 10.1016/0735-1097(88)92593-4
Steven S Khan, Sharon Nessim, Richard Gray, Lawrence S Czer, Aurelio Chaux, Jack Matloff, Increased Mortality of Women in Coronary Artery Bypass Surgery: Evidence for Referral Bias Annals of Internal Medicine. ,vol. 112, pp. 561- 567 ,(1990) , 10.7326/0003-4819-112-8-561
C. Kawas, S. Resnick, A. Morrison, R. Brookmeyer, M. Corrada, A. Zonderman, C. Bacal, D. D. Lingle, E. Metter, A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease The Baltimore Longitudinal Study of Aging Neurology. ,vol. 48, pp. 1517- 1521 ,(1997) , 10.1212/WNL.48.6.1517
Janet L. Stanford, Noel S. Weiss, Lynda F. Voight, Janet R. Daling, Laurel A. Habel, Mary Anne Rossing, Combined Estrogen and Progestin Hormone Replacement Therapy in Relation to Risk of Breast Cancer in Middle-Aged Women Obstetrical & Gynecological Survey. ,vol. 51, pp. 32- 34 ,(1996) , 10.1097/00006254-199601000-00017
S G Thompson, T W Meade, G Greenberg, The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. Journal of Epidemiology and Community Health. ,vol. 43, pp. 173- 178 ,(1989) , 10.1136/JECH.43.2.173
Hershel Jick, Laura E Derby, Marian Wald Myers, Catherine Vasilakis, Katherine M Newton, Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens The Lancet. ,vol. 348, pp. 981- 983 ,(1996) , 10.1016/S0140-6736(96)07114-0
Jay M Sullivan, Roger Vander Zwaag, Jeff P Hughes, Virginia Maddock, Frank W Kroetz, KB Ramanathan, David M Mirvis, Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. JAMA Internal Medicine. ,vol. 150, pp. 2557- 2562 ,(1990) , 10.1001/ARCHINTE.1990.00390230101014
Herman D. Movsowitz, Ronald P. Emmi, Athanassios Manginas, Elizabeth Wells, Gary S. Ledley, Morris N. Kotler, Fred K. Nakhjavan, Shahriar Yazdanfar, Directional coronary atherectomy in women compared with men. Clinical Cardiology. ,vol. 17, pp. 597- 602 ,(1994) , 10.1002/CLC.4960171106
Nanette K. Wenger, Leon Speroff, Barbara Packard, Cardiovascular Health and Disease in Women The New England Journal of Medicine. ,vol. 329, pp. 247- 256 ,(1993) , 10.1056/NEJM199307223290406